Mixed strain infections and strain-specific protective immunity in the rodent malaria parasite Plasmodium chabaudi chabaudi in mice

Infection and Immunity

Volumn 74, Issue 5, 2006, Pages 2996-3001

  Cheesman, Sandra ^a   Raza, Ahmed ^a   Carter, Richard ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DESIGN; FEMALE; GENOTYPE; HUMAN; IMMUNITY; IMMUNOLOGICAL MEMORY; MALARIA; MIXED INFECTION; NONHUMAN; PLASMODIUM CHABAUDI; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS;

ANIMALS; FEMALE; IMMUNIZATION; MALARIA; MICE; MICE, INBRED CBA; PARASITEMIA; PLASMODIUM CHABAUDI; POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY;

EID: 33646382363     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.5.2996-3001.2006     Document Type: Article

References (17)

1. Brannan, L. R., C. M. Turner, and R. S. Phillips. 1994. Malaria parasites undergo antigenic variation at high rates in vivo. Proc. R. Soc. Lond. B 256:71-75.
2. Cadigan, F. C., and V. Chiacumpa. 1969. Plasmodium falciparum in the white-handed gibbon: protection afforded by previous infection with homologous and heterologous strains obtained in Thailand. Mil. Med. 134:1135-1139.
3. Carter, R. 1978. Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinkei and P. chabaudi by starch gel electrophoresis. Parasitology 76:241-267.
4. Cheesman, S., J. de Roode, A. Read, and R. Carter. 2003. Real-time quantitative PCR for analysis of genetically mixed infections in malaria parasites: technique validation and applications. Mol. Biol. Parasitol. 131:83-91.
5. Ciuca, M., L. Ballif, and M. Chelarescu-Vieru. 1934. Immunity in malaria. Trans. R. Soc. Trop. Med. Hyg. 27:619-622.
6. Crewther, P. E., M. L. Matthew, R. H. Flegg, and R. F. Anders. 1996. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect. Immun. 64:3310-3317.
7. Desjardins, R. E., C. L. Pamplin, J. von Bredow, K. G. Barry, and C. J. Canfield. 1987. Kinetics of a new antimalarial, mefloquine, p. 262-263. In W. Peters (ed.), Chemotherapy and drug resistance in malaria, 2nd ed., vol. 1. Academic Press, Oxford, United Kingdom.
8. Elliott, S. R., R. D. Kuns, and M. F. Good. 2005. Heterologous immunity in the absence of variant-specific antibodies after exposure to subpatent infection with blood-stage malaria. Infect. Immun. 73:2478-2485.
9. Genton, B., I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, D. Pye, D. O. Irving, T. A. Smith, H.-P. Beck, and M. P. Alpers. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185:820-827.
10. Janssen, C. S., M. P. Barrett, C. M. Turner, and R. S. Phillips. 2002. A large family for putative variant antigens shared by human and rodent malaria parasites. Proc. R. Soc. Lond. B 269:431-436.
11. Jarra, W., and K. Brown. 1985. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection. Parasite Immunol. 7:595-606.
12. Jeffrey, G. M. 1966. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. W. H. O. 35:873-882.
13. Killick-Kendrick, R., and W. Peters (ed.). 1978. Rodent malaria, p. 218-219. Academic Press, London, United Kingdom.
14. Phillips, R., L. Brannan, P. Balmer, and P. Neuville. 1997. Antigenic variation during malaria infection-the contribution from the murine parasite Plasmodium chabaudi. Parasite Immunol. 9:427-434.
15. Powell, R. D., J. V. McNamara, and K. H. Rieckman. 1972. Clinical aspects of acquisition of immunity to Falciparum malaria. Proc. Helminthol. Soc. Wash. 39:51-68.
16. Renia, L., I. T. Ling, M. Marussig, F. Miltgen, A. A. Holder, and D. Mazier. 1997. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge. Infect. Immun. 65:4419-4423.
17. Rotman, H. L., T. M. Daly, and C. A. Long. 1999. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp. Parasitol. 91:78-85.